May Contain (+/-): Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499), Bismuth Oxychloride (CI 77163), Manganese Violet (CI 77742), Red 6 (CI 15850), Red 7 Lake (CI 15850), Red 21(CI 45380), Red 27 (CI 45410), Red 28 Lake (CI 45410), Red 30 Lake (CI 73360), Red 33 Lake (CI 17200), Orange 5 (CI 45370), Yellow 5 Lake (CI 19140), Yellow 6 Lake (CI 15985), Blue 1 Lake (CI 42090)
Specific GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) have demonstrated cardiovascular benefits in people with type 2 diabetes who have established cardiovascular disease or high cardiovascular risk
A potent PPARa agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle
Actualmente, la MHRA (Agencia Reguladora de Medicamentos y Productos Sanitarios) no ha aprobado ningn parche GLP-1 para adelgazar
Gao Y, Tao W, Wang S, Duan R, Zhang Z